China Pharma Holdings Reports Second Quarter 2017 Financial Results

HAIKOU CITY, China, Aug. 15, 2017 /PRNewswire/ -- China Pharma Holdings, Inc. (NYSE MKT: CPHI) ("China Pharma," the "Company" or "We"), an NYSE American listed corporation with a fully-integrated specialty pharmaceuticals subsidiary based in China, today announced financial results for the quarter ended June 30, 2017.

Second Quarter Highlights

Revenue decreased 17.7% to $2.9 million in second quarter 2017 from $3.5 million in the same period of 2016;